Revised directions for using Rabies Immune Globulin (Human), HyperRAB \u2122 S/D in fixed needle 2 mL prefilled syringe [PDF]
Tuesday, February 26, 2008, 20:15 EST (8:15 PM EST)CDCHAN-00270-2008-02-26-ADV-NThe Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have been notified by Talecris Biotherapeutics, Inc.
core
Background: Chronic inflammatory demyelinating poly-radiculoneuropathy (CIDP) is a common inflammatory neuropathy that can be progressive, stepwise progressive, or relapsing and remitting.
Bril, Vera +9 more
core +2 more sources
Refining RhIG Prophylaxis Guidelines: Asian-Type DEL as RhD-Positive and Unresolved Dosing Challenges in RhD Epitope-Deficient Variants. [PDF]
Jo J, Sung ES, Nam M, Cho D.
europepmc +1 more source
Massive fetomaternal hemorrhage and successful prevention of maternal RhD alloimmunization: A case report. [PDF]
Hassan S +4 more
europepmc +1 more source
Anti-D administration after childbirth for preventing Rhesus alloimmunisation for subsequent pregnancies. [PDF]
Kumar N +3 more
europepmc +1 more source
A multiparameter whole blood platform for assessment of anti-CMV immunity in allogeneic stem cell transplantation recipients. [PDF]
Imhof N +6 more
europepmc +1 more source
Rapid recommendations: Updates from 2024 guidelines: part 2. [PDF]
O'Toole D.
europepmc +1 more source
Patients with steroid-refractory gastrointestinal aGVHD respond to ROCK2 inhibitor rapidly. [PDF]
Yue X +7 more
europepmc +1 more source
Guideline-recommended inflammatory testing in symptomatic dermographism: a real-world study. [PDF]
Bizjak-Suran M, Stojanovič L.
europepmc +1 more source

